These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30118663)

  • 1. Cannabinoid signalling in the immature brain: Encephalopathies and neurodevelopmental disorders.
    Sagredo O; Palazuelos J; Gutierrez-Rodriguez A; Satta V; Galve-Roperh I; Martínez-Orgado J
    Biochem Pharmacol; 2018 Nov; 157():85-96. PubMed ID: 30118663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis and Endocannabinoid Signaling in Epilepsy.
    Katona I
    Handb Exp Pharmacol; 2015; 231():285-316. PubMed ID: 26408165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bench to bedside: Multiple facets of cannabinoid control in epilepsy.
    Xue B; Zhang X; Wang Y
    Neurochem Int; 2020 Dec; 141():104898. PubMed ID: 33159980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid-Based Therapies and Brain Development: Potential Harmful Effect of Early Modulation of the Endocannabinoid System.
    Schonhofen P; Bristot IJ; Crippa JA; Hallak JEC; Zuardi AW; Parsons RB; Klamt F
    CNS Drugs; 2018 Aug; 32(8):697-712. PubMed ID: 30109642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC; Patra PH; Whalley BJ
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review.
    Patil AS; Mahajan UB; Agrawal YO; Patil KR; Patil CR; Ojha S; Sharma C; Goyal SN
    Biomed Pharmacother; 2020 Dec; 132():110889. PubMed ID: 33113429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinctive Evidence Involved in the Role of Endocannabinoid Signalling in Parkinson's Disease: A Perspective on Associated Therapeutic Interventions.
    Behl T; Kaur G; Bungau S; Jhanji R; Kumar A; Mehta V; Zengin G; Brata R; Hassan SSU; Fratila O
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid signalling in embryonic and adult neurogenesis: possible implications for psychiatric and neurological disorders.
    de Oliveira RW; Oliveira CL; Guimarães FS; Campos AC
    Acta Neuropsychiatr; 2019 Feb; 31(1):1-16. PubMed ID: 29764526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoids: mechanisms and therapeutic applications in the CNS.
    Drysdale AJ; Platt B
    Curr Med Chem; 2003 Dec; 10(24):2719-32. PubMed ID: 14529462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5HT(1A) and CB2 receptors.
    Pazos MR; Mohammed N; Lafuente H; Santos M; Martínez-Pinilla E; Moreno E; Valdizan E; Romero J; Pazos A; Franco R; Hillard CJ; Alvarez FJ; Martínez-Orgado J
    Neuropharmacology; 2013 Aug; 71():282-91. PubMed ID: 23587650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical science regarding cannabinoids as analgesics: an overview.
    Lynch ME
    Pain Res Manag; 2005; 10 Suppl A():7A-14A. PubMed ID: 16237476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of lipids and lipid signaling in the development of cannabinoid tolerance.
    Martin BR
    Life Sci; 2005 Aug; 77(14):1543-58. PubMed ID: 15949820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocannabinoids and Cancer.
    Velasco G; Sánchez C; Guzmán M
    Handb Exp Pharmacol; 2015; 231():449-72. PubMed ID: 26408171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The endocannabinoid system and neurogenesis in health and disease.
    Galve-Roperh I; Aguado T; Palazuelos J; Guzmán M
    Neuroscientist; 2007 Apr; 13(2):109-14. PubMed ID: 17404371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications.
    Onaivi ES
    Int Rev Neurobiol; 2009; 88():335-69. PubMed ID: 19897083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroscience. Stout guards of the central nervous system.
    Mechoulam R; Lichtman AH
    Science; 2003 Oct; 302(5642):65-7. PubMed ID: 14526067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Interplay between the Endocannabinoid System, Epilepsy and Cannabinoids.
    Cheung KAK; Peiris H; Wallace G; Holland OJ; Mitchell MD
    Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31810321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics and Lipidomics in the Elucidation of Endocannabinoid Signaling in Healthy and Schizophrenia Brains.
    Seabra G; Falvella ACB; Guest PC; Martins-de-Souza D; de Almeida V
    Proteomics; 2018 Sep; 18(18):e1700270. PubMed ID: 30070429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid as a neuroprotective strategy in perinatal hypoxic-ischemic injury.
    Alonso-Alconada D; Alvarez A; Hilario E
    Neurosci Bull; 2011 Aug; 27(4):275-85. PubMed ID: 21788999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System.
    Zou S; Kumar U
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29533978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.